Issue 4 | September 2020 (next issue November 2020)
In this newsletter:
ECP Group News:
Journal club meeting on (1) priority setting for guideline development and (2) progression to type 2 diabetes in women with known history of gestational diabetes
Online meetup on research reproducibility and reporting
News from our Members:
Research work of Robin Vernooij on radical prostatectomy versus deferred treatment for localized prostate cancer
Research work of Emma Cartwright on partnering with patients in evidence-based medicine
Research work of Chun Hoong Wong on Oral minoxidil for alopecia
Training and Events:
COVID-19 - Cochrane resources
Workshop offering by Cochrane Malaysia
Learning Live webinars
Announcements about our next Journal Club and Online Meetup
ECP Group News
Journal Club 3:
1. Priority setting for guideline development
2. Progression to type 2 diabetes in women with known history of gestational diabetes
The third Journal Club took place on Tuesday July 14 and the recordings from the event are now available, check them out! Amena El-Harakeh presented on the topic of priority setting for guideline development. Check her presentation at this link. This was followed by a presentation on progression to type 2 diabetes in women with a known history of gestational diabetes by Elpida Vounzoulaki and the recording can be accessed using the following link.
Online Meetup 4:
Conflicted, who me? Research reproducibility and reporting.
At the fourth Online Meetup on Wednesday 16, we heard from Dr. Anisa Rowhani-Farid, Postdoctoral Fellow in the Department of Pharmaceutical Health Services Research at the University of Maryland to discuss research reproducibility and reporting. Anisa introduced us to the field of meta-research (research on research) and her summary of the ‘reproducibility crisis’ in scientific research led us into the group discussion. We discussed what actions early career researchers can take to improve the reproducibility and reporting of studies include registering protocols, ensuring data extraction is verified, and sharing data and code. We also discussed the role journals, university, and research funders play in providing incentives for researchers to be more transparent with their data and code, providing platforms on which people can share their data, and educating people about the importance of research reproducibility.
The Governing Board and Senior Management Team have been developing a new strategic framework, which will be relevant until at least 2025. Its role is to guide the work of the whole Cochrane community over this next period.
A survey has been launched asking questions about Cochrane members' and supporters' experiences of Strategy to 2020 to start the process of evaluation, which will be completed next year, and to inform any changes to the new strategy.
Complete the survey here. Read more about the draft of the next strategy here.
Closing date: 2 October 2020
News from our Members
Robin Vernooij, Post-doctoral researcher at University Medical Center Utrecht
In their recently published Cochrane Review, Robin and colleagues assess the effects of RP compared with deferred treatment/watchful waiting (WW) for clinically localised prostate cancer. Based on long-term follow-up, RP compared with WW probably results in substantially improved oncological outcomes in men with localised prostate cancer but also markedly increases rates of urinary incontinence and erectile dysfunction. @robinvernooij
Emma Cartwright, PhD student at Nanyang Technological University in Singapore and patient editor at the BMJ
Partnering with patients in evidence-based medicine (EBM) is seen as important and necessary, with patients bringing a unique perspective to evidence in healthcare. In their editorial, published in BMJ Evidence-Based Medicine, Emma Cartwright and colleague share why partnering with patients is important and highlight ways to better partner with patients in EBM. @emmajdoble
Chun Hoong Wong, Registered Pharmacist at Sultanah Amina Hospital, Malaysia
Oral minoxidil (OM) has been suggested by dermatologists as a potential remedy for patients with major presentations of alopecia. In a recent systematic review, published in the International Journal of Trichology, Chun Hoong Wong and colleagues analyze the effect of OM among patients diagnosed with any type of alopecia. The study provided very low-quality evidence about the positive effects in favor of OM highlighting the need for further research on the topic.
Have you recently published a paper, presented at a conference, written a blog, or done something amazing that you want to share? Send us a brief description, your Twitter handle, & headshot (if you wish) to firstname.lastname@example.org to be featured in our upcoming newsletter.
Training and Events
Cochrane has a dedicated page that highlights content relating to the coronavirus (COVID-19) pandemic and the various related activities that Cochrane is undertaking in response.
Cochrane Malaysia is organizing the following workshop on 17-19 November 2020: Developing a Protocol for a Cochrane Systematic Review
The next Journal Club takes place Wednesday 21 October at 14:00BST with Dr Adrián Soto Mota discussing his paper on 'Statistical illiteracy among clinicians and the ethical problems it generates.' Login details available https://bit.ly/2FPRQcv.
The next Online Meetup will take place in November on 'How to leverage social media as an early career researcher' with a special guest Muriah Umoquit (Communications and Analytics Officer, Cochrane Central Executive Team). Further details will follow!